Radiology
Boston Scientific Announces Completion of Refinancing 2011 Debt Maturities With New $3 Billion Bank Credit Facilities
June 23, 2010 4:36 am | by Boston Scientific | News | CommentsNATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the successful syndication of a new $1 billion, three-year term loan and a new $2 billion, three-year revolving credit
Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsBETHESDA, Md. , June 22 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced that it continues to expand its geographic presence with  the acquisition of Dynamic Orthotics and Prosthetics of Texas , Nebraska Orthotic and Prosthetic Services, and Spectrum Prosthetics and Orthotics...
TheraQuest Unveils New Pain Management Product Pipeline
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsBLUE BELL, Pa. , June 22 /- TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com . Najib Babul, PharmD, President and Chief...
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsLAKE FOREST, Ill. , June 22 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a...
Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsKALAMAZOO, Mich. , June 22 /- Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM)....
Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | CommentsSTEWARTVILLE, Minn. , June 22 /- Rochester Medical Corporation (Nasdaq: ROCM ) today announced that it is a winner of the fifth annual Pinnacle Award, presented by the Premier healthcare alliance. Premier contracts with more than 800 suppliers and Rochester Medical is one of 38 contracted...
Anthem Healthcare Intelligence Teams with Oracle to Offer Healthcare Analytic Applications
June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | CommentsLAS VEGAS , June 22 /- Anthem Healthcare Intelligence, Inc. is pleased to announce that they are working with Oracle to provide business intelligence and performance management applications. Anthem will offer its provider specific analytic applications on Oracle's new Enterprise...
ISYS® Search Software Wins Key Enterprise Search Contract With UNAIDS
June 22, 2010 2:35 am | by RealWire | News | CommentsISYS and Partner Raytion Selected to Provide UNAIDS With Enterprise-Wide Information Access SolutionLONDON, 22 June, 2010 - ISYS® Search Software (http://www.isys-search.com), a global supplier of enterprise search solutions for information access, management and reuse, today...
Former Medtronic executive gets top spot at Colorado spine firm
June 21, 2010 10:36 am | by Mass Device | News | CommentsMedtronic Inc.'s former chief operating officer Michael DeMane joins spinal surgery device company Lanx Inc. as chairman and CEO. By Thomas Lee Michael DeMane joined Lanx Inc. as chairman and CEO. The former chief operating officer at Medtronic Inc. (NYSE:MDT) was once...
How to become a salesperson of influence
June 21, 2010 9:35 am | by Mass Device | News | CommentsTen tips to help medical device salespeople become influential advisors to their hospital and physician customers. The other day I spoke to a sales trainer, who was a reference for a candidate. He talked about the difference between being a "pleaser" and an "adviser" to customers. The...
Sinovac Schedules 2010 Annual Meeting of Shareholders
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsBEIJING , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China , announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held...
Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City . The focus represents a growing interest and validation of how PEM can play an...
ProUroCare Medical Secures $885,000 in Financing
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS , June 17 /- ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD), a provider of proprietary imaging products, today announced that it has closed on a $885,000 private placement of debt financing. Â The funding was provided by a small group of existing investors closely...
Renhuang Wins Bid to Supply All-Natural Products to Guangzhou Military District
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsHARBIN, China , June 17 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on...
Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
June 17, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsBASKING RIDGE, N.J. , June 17 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo , PhD, President and CEO, will be presenting at the 2010 Wells Fargo Healthcare Conference at the...
TIBCO Introduces Spotfire® Clinical To Improve Clinical Trials And Accelerate Drug Development
June 17, 2010 1:36 am | by RealWire | News | CommentsNew Analytics Solution Integrates with Leading Clinical Development Systems and Supports Clinical Data Monitoring, Clinical Safety, and Clinical Operations AnalyticsLondon - June 17, 2010 - TIBCO Software Inc. (NASDAQ: TIBX) today announced the launch of TIBCO Spotfire® Clinical,...
FDA Cautions on Accurate Vitamin D Supplementation for Infants
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , June 15 /PRNewswire-USNewswire/ -- The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants. (Logo: ...
DHL Global Mail Launches Specialized Shipping Service for Mail-Order Pharmacies
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsWESTON, Fla. , June 15 /- DHL Global Mail today launched a new shipping service designed specifically around the needs of mail-order pharmacies. DHL SMARTMAIL PHARMA SELECT ™ incorporates best practices the mail expediter has established over many years of serving the pharmaceutical...
Healthy Adviceâ„¢ Networks Physicians Participate in Panel at Sales Force Effectiveness Conference
June 15, 2010 9:40 am | by Bio-Medicine.Org | News | CommentsCINCINNATI , June 15 /- Healthy Advice ™ Networks, the nation's leading provider of points-of-care health-education programs for consumers and physicians, hosted a panel of their physicians at the recent eyeforpharma Sales Force Effectiveness Conference held in Princeton, New Jersey...
Florida woman sues DePuy Orthopedics over hip implant
June 15, 2010 7:38 am | by Mass Device | News | CommentsA Florida woman sues Johnson & Johnson subsidiary DePuy Orthopedics, alleging that her ASR metal-on-metal hip replacement was defective and accusing the company of knowing about the device's problems but failing to warn physicians. DePuy Orthopaedics is facing the...
New President and Chief Executive Officer Named at Access Communications, LLC
June 15, 2010 6:40 am | by Bio-Medicine.Org | News | CommentsBERKELEY HEIGHTS, N.J. , June 15 /- Access Communications, LLC (Access) has named David P. Gagliano the company's president and chief executive officer (CEO). Since mid-2009, Access was under the leadership of a group of managing partners, a role in which Gagliano served in addition to...
Access Communications, LLC Wins Four Creative Design Awards from the Art Directors Club of New Jersey
June 15, 2010 6:40 am | by Bio-Medicine.Org | News | CommentsBERKELEY HEIGHTS, N.J. , June 15 /- Access Communications, LLC (Access) has been awarded four distinctions of honor for its creative expertise from the Art Directors Club of New Jersey (ADCNJ). The most notable ADCNJ recognition for 2009 is the agency's Medal Award for the creative design...
Perrigo Company to Present at the 31st Annual Goldman Sachs Global Healthcare Conference
June 15, 2010 6:39 am | by Bio-Medicine.Org | News | CommentsALLEGAN, Mich. , June 15 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and CFO Judy Brown will present at the 31st Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 15 , at 3:05 p.m. (PT) at the Hyatt Regency Century Plaza...
Healthcare matchmaker WellClicks raises $1 million
June 15, 2010 6:39 am | by Mass Device | News | CommentsWellClicks, a startup aiming to connect consumers with healthcare providers that match their preferences, drums up $1 million in an equity offering. By Brandon Glenn WellClicks, a startup that promises to match consumers with health providers, raised $1 million from seven...
Surplus PC Power Yields Faster Cancer Research
June 15, 2010 4:42 am | by IBM | News | CommentsScientists have devised a way to automate and accelerate a manual, complex process that enables researchers to more easily discover the structure of cancer-related proteins, and, eventually, formulate cancer cures. This new, automated approach may also help the exploration of other...
